Daratumumab with the CAS number 945721-28-8 represents a groundbreaking therapeutic agent, specifically designed to target CD38, an antigen present on the surface of blood cells. Its how it works involves multiple https://www.targetmol.com/compound/daratumumab
Daratumumab 945721-28-8: A Deep Dive into its Properties
Internet - 4 hours ago daratumumab255415Web Directory Categories
Web Directory Search
New Site Listings